agilon health Second Quarter 2025 Earnings: Misses Expectations

Simply Wall St · 08/06/2025 10:49
NYSE:AGL 1 Year Share Price vs Fair Value
NYSE:AGL 1 Year Share Price vs Fair Value
Explore agilon health's Fair Values from the Community and select yours

agilon health (NYSE:AGL) Second Quarter 2025 Results

Key Financial Results

  • Revenue: US$1.39b (down 5.9% from 2Q 2024).
  • Net loss: US$104.4m (loss widened by 240% from 2Q 2024).
  • US$0.25 loss per share (further deteriorated from US$0.075 loss in 2Q 2024).
earnings-and-revenue-growth
NYSE:AGL Earnings and Revenue Growth August 6th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

agilon health Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 5.2%. Earnings per share (EPS) also missed analyst estimates by 114%.

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are down 54% from a week ago.

Risk Analysis

You still need to take note of risks, for example - agilon health has 2 warning signs (and 1 which doesn't sit too well with us) we think you should know about.